2m 2m 2m 2m 2m 2m 2m
TARSUS PHARMA (TARS)
NASDAQ
$79.33+$0.02 (+0.03%)
Price as of Sep 11, 2026 7:30 PM EDT- $3.5BMarket Cap
- 60.68%1-Year Change
- BiotechnologyIndustry
TARSUS PHARMA (TARS)
$79.33+$0.02 (+0.03%)
TARS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $79.31 | ||
Change | -$1.81 (-2.23%) | ||
Open | $82.27 | ||
High | $83.22 | ||
Low | $79.17 | ||
Previous Close | $81.12 | ||
Volume | 490,786 | ||
30-Day Average Volume | 778,274 | ||
1-Week Change | -12.63% | ||
1-Month Change | 14.18% | ||
1-Year Change | 60.68% | ||
3-Year Change | 367.08% | ||
5-Year Change | 255.65% | ||
Fundamentals | |||
Shares Outstanding | 43.9M | ||
Total Assets | $611.1M | ||
Market Cap | $3.5B | ||
Enterprise Value | $3.3B | ||
Period: QTR TTM FY | |||
Revenue | $173.9M | ||
Net Income | -$18.6M | ||
Free Cash Flow | $57.2M | ||
EBIT | -$13.7M | ||
EBITDA | -$13.4M | ||
Net Working Capital | $386.2M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -249 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 10 | ||
P/E | -184 | ||
PEG | 1 | ||
Price/Free Cash Flow | 61 | ||
Price/Operating Cash Flow | 57 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue